A 52-week randomized safety study of a calcipotriol/betamethasone dipropionate two-compound product (Dovobet®/Daivobet®/Taclonex®) in the treatment of psoriasis vulgaris
✍ Scribed by K. Kragballe; J. Austad; L. Barnes; A. Bibby; M. De La Brassinne; F. Cambazard; C. Fleming; H. Heikkilä; D. Jolliffe; J. Peyri; Å. Svensson; J. Toole; G. Wozel
- Book ID
- 108668792
- Publisher
- John Wiley and Sons
- Year
- 2006
- Tongue
- English
- Weight
- 160 KB
- Volume
- 154
- Category
- Article
- ISSN
- 0007-0963
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A clinical study was conducted to determine whether, in the topical treatment of psoriasis, a combination of calcipotriol and betamethasone valerate after previous treatment with calcipotriol alone was more effective than the continuation of the monotherapy with calcipotriol, especially in 'low resp
## Background: Calcipotriol and betamethasone dipropionate are both widely used, effective treatments for psoriasis. vitamin d analogues and topical corticosteroids have different mechanisms of action in the treatment of psoriasis. a new vehicle has been developed in order to contain both calcipotr